A novel approach to studying the relationship between subjective and objective measures of cough

Angela Kelsall, Lesley A. Houghton, Helen Jones, Samantha Decalmer, Kevin McGuinness, Jaclyn A. Smith

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: Currently, no data are available on the relationship between changes in objective and subjective measures of cough, the magnitude of change in cough frequency perceived by patients as clinically meaningful, or the sample sizes required to show significant changes in cough therapeutic trials. Because patients anecdotally report reductions in cough severity while undergoing esophageal testing, we aimed to address these issues by assessing objective and subjective measures of cough with and without an esophageal catheter. Methods: Twenty-four-hour cough monitoring was performed on two occasions, with and without esophageal impedance/pH monitoring in 62 patients with chronic cough (mean age 56.8 years [SD ± 10.8]; 43 women; median cough duration 3.3 years [interquartile range (IQR), 2.0-10.0]). Cough was assessed objectively measuring coughs per hour and subjectively using a numerical cough score and a visual analog scale (VAS), scored separately for day and night, and then averaged to represent each 24-h period. Results: Objective cough frequency was reduced by a median of 33.3% (IQR, -68.8% to -13.0%; P < .001) with the catheter. The averaged day and night cough scores and VAS scores also significantly decreased, but changes in these did not correlate with decreases in cough frequency. Sample-size calculations suggested that crossover designs using objective cough frequency may be preferable in therapeutic trials. Conclusions: These observations provide useful information on the reduction in objective cough frequency scored as an improvement by patients with chronic cough and offer guidance for the design and powering of future therapeutic trials. Trial registry: ISRCTN; No.: ISRCTN62337037; URL: http://www.controlled- trials.com.

Original languageEnglish (US)
Pages (from-to)569-575
Number of pages7
JournalChest
Volume139
Issue number3
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Cough
Visual Analog Scale
Sample Size
Catheters
Esophageal pH Monitoring
Electric Impedance
Cross-Over Studies
Registries

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Kelsall, A., Houghton, L. A., Jones, H., Decalmer, S., McGuinness, K., & Smith, J. A. (2011). A novel approach to studying the relationship between subjective and objective measures of cough. Chest, 139(3), 569-575. https://doi.org/10.1378/chest.10-0438

A novel approach to studying the relationship between subjective and objective measures of cough. / Kelsall, Angela; Houghton, Lesley A.; Jones, Helen; Decalmer, Samantha; McGuinness, Kevin; Smith, Jaclyn A.

In: Chest, Vol. 139, No. 3, 01.03.2011, p. 569-575.

Research output: Contribution to journalArticle

Kelsall, A, Houghton, LA, Jones, H, Decalmer, S, McGuinness, K & Smith, JA 2011, 'A novel approach to studying the relationship between subjective and objective measures of cough', Chest, vol. 139, no. 3, pp. 569-575. https://doi.org/10.1378/chest.10-0438
Kelsall A, Houghton LA, Jones H, Decalmer S, McGuinness K, Smith JA. A novel approach to studying the relationship between subjective and objective measures of cough. Chest. 2011 Mar 1;139(3):569-575. https://doi.org/10.1378/chest.10-0438
Kelsall, Angela ; Houghton, Lesley A. ; Jones, Helen ; Decalmer, Samantha ; McGuinness, Kevin ; Smith, Jaclyn A. / A novel approach to studying the relationship between subjective and objective measures of cough. In: Chest. 2011 ; Vol. 139, No. 3. pp. 569-575.
@article{43357d8ff35943bd81a2e61bb505410c,
title = "A novel approach to studying the relationship between subjective and objective measures of cough",
abstract = "Background: Currently, no data are available on the relationship between changes in objective and subjective measures of cough, the magnitude of change in cough frequency perceived by patients as clinically meaningful, or the sample sizes required to show significant changes in cough therapeutic trials. Because patients anecdotally report reductions in cough severity while undergoing esophageal testing, we aimed to address these issues by assessing objective and subjective measures of cough with and without an esophageal catheter. Methods: Twenty-four-hour cough monitoring was performed on two occasions, with and without esophageal impedance/pH monitoring in 62 patients with chronic cough (mean age 56.8 years [SD ± 10.8]; 43 women; median cough duration 3.3 years [interquartile range (IQR), 2.0-10.0]). Cough was assessed objectively measuring coughs per hour and subjectively using a numerical cough score and a visual analog scale (VAS), scored separately for day and night, and then averaged to represent each 24-h period. Results: Objective cough frequency was reduced by a median of 33.3{\%} (IQR, -68.8{\%} to -13.0{\%}; P < .001) with the catheter. The averaged day and night cough scores and VAS scores also significantly decreased, but changes in these did not correlate with decreases in cough frequency. Sample-size calculations suggested that crossover designs using objective cough frequency may be preferable in therapeutic trials. Conclusions: These observations provide useful information on the reduction in objective cough frequency scored as an improvement by patients with chronic cough and offer guidance for the design and powering of future therapeutic trials. Trial registry: ISRCTN; No.: ISRCTN62337037; URL: http://www.controlled- trials.com.",
author = "Angela Kelsall and Houghton, {Lesley A.} and Helen Jones and Samantha Decalmer and Kevin McGuinness and Smith, {Jaclyn A.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1378/chest.10-0438",
language = "English (US)",
volume = "139",
pages = "569--575",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "3",

}

TY - JOUR

T1 - A novel approach to studying the relationship between subjective and objective measures of cough

AU - Kelsall, Angela

AU - Houghton, Lesley A.

AU - Jones, Helen

AU - Decalmer, Samantha

AU - McGuinness, Kevin

AU - Smith, Jaclyn A.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Background: Currently, no data are available on the relationship between changes in objective and subjective measures of cough, the magnitude of change in cough frequency perceived by patients as clinically meaningful, or the sample sizes required to show significant changes in cough therapeutic trials. Because patients anecdotally report reductions in cough severity while undergoing esophageal testing, we aimed to address these issues by assessing objective and subjective measures of cough with and without an esophageal catheter. Methods: Twenty-four-hour cough monitoring was performed on two occasions, with and without esophageal impedance/pH monitoring in 62 patients with chronic cough (mean age 56.8 years [SD ± 10.8]; 43 women; median cough duration 3.3 years [interquartile range (IQR), 2.0-10.0]). Cough was assessed objectively measuring coughs per hour and subjectively using a numerical cough score and a visual analog scale (VAS), scored separately for day and night, and then averaged to represent each 24-h period. Results: Objective cough frequency was reduced by a median of 33.3% (IQR, -68.8% to -13.0%; P < .001) with the catheter. The averaged day and night cough scores and VAS scores also significantly decreased, but changes in these did not correlate with decreases in cough frequency. Sample-size calculations suggested that crossover designs using objective cough frequency may be preferable in therapeutic trials. Conclusions: These observations provide useful information on the reduction in objective cough frequency scored as an improvement by patients with chronic cough and offer guidance for the design and powering of future therapeutic trials. Trial registry: ISRCTN; No.: ISRCTN62337037; URL: http://www.controlled- trials.com.

AB - Background: Currently, no data are available on the relationship between changes in objective and subjective measures of cough, the magnitude of change in cough frequency perceived by patients as clinically meaningful, or the sample sizes required to show significant changes in cough therapeutic trials. Because patients anecdotally report reductions in cough severity while undergoing esophageal testing, we aimed to address these issues by assessing objective and subjective measures of cough with and without an esophageal catheter. Methods: Twenty-four-hour cough monitoring was performed on two occasions, with and without esophageal impedance/pH monitoring in 62 patients with chronic cough (mean age 56.8 years [SD ± 10.8]; 43 women; median cough duration 3.3 years [interquartile range (IQR), 2.0-10.0]). Cough was assessed objectively measuring coughs per hour and subjectively using a numerical cough score and a visual analog scale (VAS), scored separately for day and night, and then averaged to represent each 24-h period. Results: Objective cough frequency was reduced by a median of 33.3% (IQR, -68.8% to -13.0%; P < .001) with the catheter. The averaged day and night cough scores and VAS scores also significantly decreased, but changes in these did not correlate with decreases in cough frequency. Sample-size calculations suggested that crossover designs using objective cough frequency may be preferable in therapeutic trials. Conclusions: These observations provide useful information on the reduction in objective cough frequency scored as an improvement by patients with chronic cough and offer guidance for the design and powering of future therapeutic trials. Trial registry: ISRCTN; No.: ISRCTN62337037; URL: http://www.controlled- trials.com.

UR - http://www.scopus.com/inward/record.url?scp=79952208898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952208898&partnerID=8YFLogxK

U2 - 10.1378/chest.10-0438

DO - 10.1378/chest.10-0438

M3 - Article

VL - 139

SP - 569

EP - 575

JO - Chest

JF - Chest

SN - 0012-3692

IS - 3

ER -